Many in-vitro anticancer, mechanistic studies have been reported to use Tamoxifen (TAM) as a positive control for Estrogen Receptor + (ER+) breast cancer cells like MCF-7. But what will be an ideal positive control for in-vitro mechanistic studies involving triple negative breast cancer cells like MDA-MB-231 in ?